RA CAPITAL MANAGEMENT, L.P. bought VOR

August 24, 2026 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 1,500 shares of Vor Biopharma Inc. at $3.74 per share, a transaction worth $5.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,500
Price
$3.74
Total value
$5.6K
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 24, 2026
Filing dateAugust 26, 2026
Shares owned after1,500
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

On September 18, 2025, the Issuer effected a 1-for-20 reverse stock split. The exercise price and number of shares underlying the stock option give effect to the reverse stock split.; RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; This option was granted to Joshua Resnick pursuant to the Issuer's non-employee director compensation policy. Under Mr. Resnick's arrangement with the Adviser, Mr. Resnick held the option for the benefit of the Fund. Mr. Resnick is obligated to turn over to the Adviser any stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.

View the original Form 4 on SEC EDGAR